We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toThe-Metamorphosis-of-Clinical-Trials-Evolving-Roles-of-Stakeholders-in-Digital-Trials

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

The Metamorphosis of Clinical Trials: Evolving Roles of Stakeholders in Digital Trials

    Session Chair(s)
      Josh  Rose, MBA

      Josh Rose, MBA

      • Vice President, Global Head of Strategy
      • IQVIA, United States
    This session will examine the promise of virtual trials to address challenges of traditional site-based models by examining the evolving roles of study stakeholders, patients, investigators, and study managers, and how they improve study performance
    Learning Objective : Describe the potential promise, benefits, and considerations of virtual clinical trials to address challenges to clinical trial conduct and participation; Define the evolution of stakeholder roles, existing and new, and the interplay between them, in virtual/direct to patient clinical trials; Apply insights to inform virtual trial design and planning.
      Angela  Botto-van Bemden, PhD


      Angela Botto-van Bemden, PhD

      • Director, OA Programs
      • Arthritis Foundation, United States
      Murray Alexander Abramson, DrMed, MPH


      Murray Alexander Abramson, DrMed, MPH

      • Vice President, Global Clinical Operations
      • Biogen Inc., United States
      Jeff  Kingsley, DO, MBA


      Jeff Kingsley, DO, MBA

      • Cheif Executive Officer
      • IACT Health, United States